ArticleSupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer2025
Colorectal cancer survivorship program at a single tertiary centre: has service provision changed after COVID-19?
Article in Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundSurveillance after colorectal cancer (CRC) resection is an important aspect of survivorship care. This study aimed to assess whether there were any changes to post-operative surveillance uptake in non-metastatic CRC patients and pre- and post-COVID pandemic in Victoria.
methodsAll CRC patients (Stages I-III) who underwent curative surgery at Western Health, Victoria, Australia, were included. Surveillance included a three-monthly clinical review and carcinoembryonic antigen (CEA) up to 18 months and CT imaging and colonoscopy at 12 months following surgical resection.
resultsBetween 2019 and 2022, 380 patients were identified. Stage III patients had the highest uptake with regard to clinical reviews, CEA testing and 12-month CT (83.3%, 60.3% and 85.5%, respectively) while Stage I patients had the lowest (52.7%, 35.7% and 75.5% respectively) (p < 0.05). Colonoscopy surveillance was low regardless of stage (66.3%, 59.8% and 59.7% of Stages I, II and III, respectively). Uptake of CEA, clinic reviews and colonoscopy did not vary during our study period. More patients underwent 12-month CT following the COVID pandemic (87%) compared to pre-COVID (73.1%) or during COVID (76%, p < 0.05). There was no difference in 18-month mortality and overall recurrence during our study timelines.
conclusionLower-stage CRC patients had lower rates of surveillance uptake, in particular, with CEA blood tests and colonoscopy. Survivorship provision did not change pre- or post-COVID.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.